Title | Synthesis of a boron-containing amidoxime reagent and its application to synthesize functionalized oxadiazole and quinazolinone derivatives. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Das BC, Nandwana NK, Ojha DP, Das S, Evans T |
Journal | Tetrahedron Lett |
Volume | 92 |
Date Published | 2022 Mar 02 |
ISSN | 0040-4039 |
Abstract | <p>Herein, we report the design, synthesis and application of a borylated amidoxime reagent for the direct synthesis of functionalized oxadiazole and quinazolinone derivatives. This reagent exhibits broad synthetic utility to obtain a variety of biologically relevant drug-like molecules. It can be easily prepared at large scale from relatively inexpensive reagents, and can undergo facile transformations to obtain target compounds. The developed amidoxime reagent was synthesized from 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile and hydroxyl amine hydrochloride using -diisopropylethylamine as a base in ethanol under reflux conditions. Overall advantages include a metal-free route to boronated oxadiazoles, quinazolinone derivatives, and restriction of the multistep sequences. Importantly, the boron-rich pharmacophore derived compounds were obtained through an efficient and inexpensive strategy.</p> |
DOI | 10.1016/j.tetlet.2022.153657 |
Alternate Journal | Tetrahedron Lett |
PubMed ID | 35935920 |
PubMed Central ID | PMC9348647 |
Grant List | R01 AI132614 / AI / NIAID NIH HHS / United States R01 NS109423 / NS / NINDS NIH HHS / United States R21 AA027374 / AA / NIAAA NIH HHS / United States |